Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Aust J Prim Health ; 27(5): 377-381, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34706813

ABSTRACT

When people face a health problem, they often first ask, 'Is there an app for that?'. We investigated the quality of advice provided by the Ada symptom assessment application to address the question, 'How do I know the app on my phone is safe and provides good advice?'. The app was tested with 48 independently created vignettes developed for a previous study, including 18 specifically developed for the Australian setting, using an independently developed methodology to evaluate the accuracy of condition suggestions and urgency advice. The correct condition was listed first in 65% of vignettes, and in the Top 3 results in 83% of vignettes. The urgency advice in the app exactly matched the gold standard 63% of vignettes. The app's accuracy of condition suggestion and urgency advice is higher than that of the best-performing symptom assessment app reported in a previous study (61%, 77% and 52% for conditions suggested in the Top 1, Top 3 and exactly matching urgency advice respectively). These results are relevant to the application of symptom assessment in primary and community health, where medical quality and safety should determine app choice.


Subject(s)
Mobile Applications , Australia , Humans , Symptom Assessment
2.
JMIR Form Res ; 5(5): e26402, 2021 May 21.
Article in English | MEDLINE | ID: mdl-34018963

ABSTRACT

BACKGROUND: Crowding can negatively affect patient and staff experience, and consequently the performance of health care facilities. Crowding can potentially be eased through streamlining and the reduction of duplication in patient history-taking through the use of a digital symptom-taking app. OBJECTIVE: We simulated the introduction of a digital symptom-taking app on patient flow. We hypothesized that waiting times and crowding in an urgent care center (UCC) could be reduced, and that this would be more efficient than simply adding more staff. METHODS: A discrete-event approach was used to simulate patient flow in a UCC during a 4-hour time frame. The baseline scenario was a small UCC with 2 triage nurses, 2 doctors, 1 treatment/examination nurse, and 1 discharge administrator in service. We simulated 33 scenarios with different staff numbers or different potential time savings through the app. We explored average queue length, waiting time, idle time, and staff utilization for each scenario. RESULTS: Discrete-event simulation showed that even a few minutes saved through patient app-based self-history recording during triage could result in significantly increased efficiency. A modest estimated time saving per patient of 2.5 minutes decreased the average patient wait time for triage by 26.17%, whereas a time saving of 5 minutes led to a 54.88% reduction in patient wait times. Alternatively, adding an additional triage nurse was less efficient, as the additional staff were only required at the busiest times. CONCLUSIONS: Small time savings in the history-taking process have potential to result in substantial reductions in total patient waiting time for triage nurses, with likely effects of reduced patient anxiety, staff anxiety, and improved patient care. Patient self-history recording could be carried out at home or in the waiting room via a check-in kiosk or a portable tablet computer. This formative simulation study has potential to impact service provision and approaches to digitalization at scale.

4.
BMJ Open ; 10(12): e040269, 2020 12 16.
Article in English | MEDLINE | ID: mdl-33328258

ABSTRACT

OBJECTIVES: To compare breadth of condition coverage, accuracy of suggested conditions and appropriateness of urgency advice of eight popular symptom assessment apps. DESIGN: Vignettes study. SETTING: 200 primary care vignettes. INTERVENTION/COMPARATOR: For eight apps and seven general practitioners (GPs): breadth of coverage and condition-suggestion and urgency advice accuracy measured against the vignettes' gold-standard. PRIMARY OUTCOME MEASURES: (1) Proportion of conditions 'covered' by an app, that is, not excluded because the user was too young/old or pregnant, or not modelled; (2) proportion of vignettes with the correct primary diagnosis among the top 3 conditions suggested; (3) proportion of 'safe' urgency advice (ie, at gold standard level, more conservative, or no more than one level less conservative). RESULTS: Condition-suggestion coverage was highly variable, with some apps not offering a suggestion for many users: in alphabetical order, Ada: 99.0%; Babylon: 51.5%; Buoy: 88.5%; K Health: 74.5%; Mediktor: 80.5%; Symptomate: 61.5%; Your.MD: 64.5%; WebMD: 93.0%. Top-3 suggestion accuracy was GPs (average): 82.1%±5.2%; Ada: 70.5%; Babylon: 32.0%; Buoy: 43.0%; K Health: 36.0%; Mediktor: 36.0%; Symptomate: 27.5%; WebMD: 35.5%; Your.MD: 23.5%. Some apps excluded certain user demographics or conditions and their performance was generally greater with the exclusion of corresponding vignettes. For safe urgency advice, tested GPs had an average of 97.0%±2.5%. For the vignettes with advice provided, only three apps had safety performance within 1 SD of the GPs-Ada: 97.0%; Babylon: 95.1%; Symptomate: 97.8%. One app had a safety performance within 2 SDs of GPs-Your.MD: 92.6%. Three apps had a safety performance outside 2 SDs of GPs-Buoy: 80.0% (p<0.001); K Health: 81.3% (p<0.001); Mediktor: 87.3% (p=1.3×10-3). CONCLUSIONS: The utility of digital symptom assessment apps relies on coverage, accuracy and safety. While no digital tool outperformed GPs, some came close, and the nature of iterative improvements to software offers scalable improvements to care.


Subject(s)
General Practitioners , Humans , Mobile Applications , Primary Health Care , Symptom Assessment
5.
Open Biol ; 3(10): 130065, 2013 Oct 23.
Article in English | MEDLINE | ID: mdl-24153002

ABSTRACT

Autosomal recessive primary microcephaly (MCPH) is a congenital disorder characterized by significantly reduced brain size and mental retardation. Nine genes are currently known to be associated with the condition, all of which encode centrosomal or spindle pole proteins. MCPH is associated with a reduction in proliferation of neural progenitors during fetal development. The cellular mechanisms underlying the proliferation defect, however, are not fully understood. The zebrafish retinal neuroepithelium provides an ideal system to investigate this question. Mutant or morpholino-mediated knockdown of three known MCPH genes (stil, aspm and wdr62) and a fourth centrosomal gene, odf2, which is linked to several MCPH proteins, results in a marked reduction in head and eye size. Imaging studies reveal a dramatic rise in the fraction of proliferating cells in mitosis in all cases, and time-lapse microscopy points to a failure of progression through prometaphase. There was also increased apoptosis in all the MCPH models but this appears to be secondary to the mitotic defect as we frequently saw mitotically arrested cells disappear, and knocking down p53 apoptosis did not rescue the mitotic phenotype, either in whole retinas or clones.


Subject(s)
Metaphase , Retina/embryology , Retina/metabolism , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Apoptosis/genetics , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Line, Transformed , Disease Models, Animal , Embryonic Development , Evolution, Molecular , Eye Abnormalities/embryology , Eye Abnormalities/genetics , Eye Abnormalities/metabolism , Gene Knockdown Techniques , Genes, p53 , Head/abnormalities , Head/embryology , Humans , Microcephaly/genetics , Microcephaly/metabolism , Microcephaly/physiopathology , Mitosis/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Retina/cytology , Retinal Neurons/cytology , Retinal Neurons/metabolism , Stem Cells/cytology , Time-Lapse Imaging , Zebrafish/embryology , Zebrafish/genetics
6.
Open Biol ; 3(4): 120167, 2013 Apr 10.
Article in English | MEDLINE | ID: mdl-23576785

ABSTRACT

Several studies have successfully produced a variety of neural cell types from human embryonic stem cells (hESCs), but there has been limited systematic analysis of how different regional identities are established using well-defined differentiation conditions. We have used adherent, chemically defined cultures to analyse the roles of Activin/Nodal, bone morphogenetic protein (BMP), fibroblast growth factor (FGF) and Wnt/ß-catenin signalling in neural induction, anteroposterior patterning and eye field specification in hESCs. We show that either BMP inhibition or activation of FGF signalling is required for effective neural induction, but these two pathways have distinct outcomes on rostrocaudal patterning. While BMP inhibition leads to specification of forebrain/midbrain positional identities, FGF-dependent neural induction is associated with strong posteriorization towards hindbrain/spinal cord fates. We also demonstrate that Wnt/ß-catenin signalling is activated during neural induction and promotes acquisition of neural fates posterior to forebrain. Therefore, inhibition of this pathway is needed for efficient forebrain specification. Finally, we provide evidence that the levels of Activin/Nodal and BMP signalling have a marked influence on further forebrain patterning and that constitutive inhibition of these pathways represses expression of eye field genes. These results show that the key mechanisms controlling neural patterning in model vertebrate species are preserved in adherent, chemically defined hESC cultures and reveal new insights into the signals regulating eye field specification.


Subject(s)
Activins/metabolism , Bone Morphogenetic Proteins/metabolism , Embryonic Stem Cells/metabolism , Fibroblast Growth Factors/metabolism , Nodal Protein/metabolism , Wnt Proteins/metabolism , beta Catenin/metabolism , Activins/antagonists & inhibitors , Benzamides/pharmacology , Bone Morphogenetic Proteins/antagonists & inhibitors , Carrier Proteins/pharmacology , Cells, Cultured , Dioxoles/pharmacology , Embryonic Stem Cells/cytology , Fibroblast Growth Factor 2/pharmacology , Gene Expression Regulation, Developmental/drug effects , Hedgehog Proteins/metabolism , Humans , Neural Plate/metabolism , Nodal Protein/antagonists & inhibitors , Signal Transduction/drug effects , Up-Regulation/drug effects , Wnt Proteins/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...